tiprankstipranks
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market
CGON
CG Oncology, Inc.
RESEARCH TOOLSreports
Want to see CGON full AI Analyst Report?

CG Oncology, Inc. (CGON) Ratios

316 Followers

CG Oncology, Inc. Ratios

CGON's free cash flow for Q1 2026 was $-1.73. For the 2026 fiscal year, CGON's free cash flow was decreased by $ and operating cash flow was $-61.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 31.30 24.63 35.30 13.62 9.54
Quick Ratio
 31.25 24.58 35.30 13.62 9.54
Cash Ratio
 0.96 1.05 12.03 0.58 5.71
Solvency Ratio
 -4.24 -4.09 -4.11 -3.35 -1.57
Operating Cash Flow Ratio
 -4.54 -4.29 -3.68 -3.20 -1.93
Short-Term Operating Cash Flow Coverage
 -150.11 -144.64 0.00 -80.28 -3.32
Net Current Asset Value
$ 1.06B$ 720.49M$ 732.79M$ 179.61M$ 124.64M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.11
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.13
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.11
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.05
Financial Leverage Ratio
 1.04 1.05 1.03 1.08 1.18
Debt Service Coverage Ratio
 -185.73 -174.37 0.00 -97.42 -3.93
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -35.25K
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 0.09 0.09 <0.01 0.02 0.24
Net Debt to EBITDA
 0.13 0.16 2.24 0.13 2.05
Profitability Margins
Gross Profit Margin
-46.97%-15.02%100.00%100.00%92.15%
EBIT Margin
-3948.87%-3985.02%-10067.25%-27180.88%-18453.40%
EBITDA Margin
-3904.26%-3949.26%-10064.44%-27172.55%-18445.55%
Operating Profit Margin
-4238.99%-4722.13%-10067.25%-27180.88%-18453.40%
Pretax Profit Margin
-3682.61%-3985.02%-7729.50%-23826.96%-18556.54%
Net Profit Margin
-3682.61%-3985.02%-7729.50%-23826.96%-18556.54%
Continuous Operations Profit Margin
-3682.61%-3985.02%-7729.50%-23826.96%-18556.54%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
86.87%84.39%76.78%87.66%100.56%
Return on Assets (ROA)
-16.45%-20.34%-11.66%-24.39%-23.99%
Return on Equity (ROE)
-23.33%-21.39%-12.00%-26.30%-28.31%
Return on Capital Employed (ROCE)
-19.54%-25.08%-15.63%-29.96%-26.64%
Return on Invested Capital (ROIC)
-19.52%-25.05%-15.63%-29.84%-24.91%
Return on Tangible Assets
-16.61%-20.62%-11.66%-24.39%-23.99%
Earnings Yield
-3.44%-5.02%-4.91%-1.96%-1.43%
Efficiency Ratios
Receivables Turnover
 3.98 5.87 1.46 2.22 0.63
Payables Turnover
 0.90 0.81 0.00 0.00 0.02
Inventory Turnover
 4.99 2.97 0.00 0.00 0.00
Fixed Asset Turnover
 0.26 0.21 2.31 0.42 0.38
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Cash Conversion Cycle
 -238.46 -263.73 250.28 164.61 -23.39K
Days of Sales Outstanding
 91.77 62.16 250.28 164.61 579.03
Days of Inventory Outstanding
 73.12 122.92 0.00 0.00 0.00
Days of Payables Outstanding
 403.35 448.81 0.00 0.00 23.97K
Operating Cycle
 164.89 185.08 250.28 164.61 579.03
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.89 -1.71 -1.26 -0.69 -0.45
Free Cash Flow Per Share
 -1.90 -1.71 -1.26 -0.69 -0.45
CapEx Per Share
 <0.01 <0.01 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -379.18 -987.66 -336.38 0.00 -2.13K
Capital Expenditure Coverage Ratio
 -379.18 -987.66 -336.38 0.00 -2.13K
Operating Cash Flow Coverage Ratio
 -21.12 -18.85 -330.73 -44.35 -1.87
Operating Cash Flow to Sales Ratio
 -31.55 -32.76 -69.11 -223.92 -156.04
Free Cash Flow Yield
-2.83%-4.13%-4.40%-1.84%-1.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -29.08 -19.94 -20.36 -50.96 -69.88
Price-to-Sales (P/S) Ratio
 1.12K 794.47 1.57K 12.14K 12.97K
Price-to-Book (P/B) Ratio
 4.97 4.26 2.44 13.40 19.79
Price-to-Free Cash Flow (P/FCF) Ratio
 -35.32 -24.23 -22.70 -54.22 -83.07
Price-to-Operating Cash Flow Ratio
 -33.94 -24.25 -22.77 -54.22 -83.11
Price-to-Earnings Growth (PEG) Ratio
 0.74 -0.42 -0.53 -0.93 -0.51
Price-to-Fair Value
 4.97 4.26 2.44 13.40 19.79
Enterprise Value Multiple
 -28.49 -19.96 -13.40 -44.55 -68.25
Enterprise Value
 5.64B 3.18B 1.54B 2.47B 2.40B
EV to EBITDA
 -28.49 -19.96 -13.40 -44.55 -68.25
EV to Sales
 1.11K 788.16 1.35K 12.11K 12.59K
EV to Free Cash Flow
 -35.16 -24.04 -19.45 -54.06 -80.64
EV to Operating Cash Flow
 -35.25 -24.06 -19.51 -54.06 -80.68
Tangible Book Value Per Share
 12.79 9.60 11.73 2.77 1.88
Shareholders’ Equity Per Share
 12.92 9.74 11.73 2.77 1.88
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.06 0.05 0.02 <0.01 <0.01
Net Income Per Share
 -2.21 -2.08 -1.41 -0.73 -0.53
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.93 1.00 0.77 0.88 1.01
Research & Development to Revenue
 26.21 28.87 72.08 224.27 151.98
SG&A to Revenue
 15.68 18.20 29.59 48.53 33.55
Stock-Based Compensation to Revenue
 4.24 6.60 10.01 7.49 3.54
Income Quality
 0.86 0.82 0.89 0.94 0.84
Currency in USD